Editas Medicine, Inc. (EDIT)
2.51
-0.07
(-2.71%)
USD |
NASDAQ |
Oct 21, 16:00
2.50
-0.01
(-0.40%)
After-Hours: 20:00
Editas Medicine Net Income (Annual) : -160.06M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -160.06M |
| December 31, 2024 | -237.09M |
| December 31, 2023 | -153.22M |
| December 31, 2022 | -220.43M |
| December 31, 2021 | -192.50M |
| December 31, 2020 | -115.98M |
| Date | Value |
|---|---|
| December 31, 2019 | -133.75M |
| December 31, 2018 | -109.95M |
| December 31, 2017 | -120.32M |
| December 31, 2016 | -97.18M |
| December 31, 2015 | -72.90M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Recursion Pharmaceuticals, Inc. | -644.76M |
| Geron Corp. | -83.50M |
| Halozyme Therapeutics, Inc. | 316.89M |
| Novavax, Inc. | 440.30M |
| AVITA Medical, Inc. | -48.59M |